Skip to main content
. 2023 Feb 1;60:102623. doi: 10.1016/j.redox.2023.102623

Table 1.

Demographic and clinical characteristics, Univariate and Multivariate analysis of AIS group and healthy control group.

Characteristics Healthy control group, n = 107 AIS group, n = 328 Univariate and Multivariate analysis
Multivariate analysis
OR (95%CI) SE P value OR (95%CI) SE P value
Age, y 66.81 ± 10.39 68.48 ± 11.14 1.01 (1.00–1.03) 0.009 0.173 / / /
Men, n(%) 64(59.81) 227(69.21) 1.01(0.93–1.11) 0.05 0.756 / / /
BMI(kg/m2) 24.65 ± 2.97 24.18 ± 3.07 0.95 (0.88–1.02) 0.033 0.167 / / /
Hypertension(%) 58(54.2) 231(70.43) 2.66 (1.69–4.20) 0.62 <0.05 4.14 (1.84–9.33) 1.72 0.001
CHD(%) 8(7.48) 43(13.10) 1.86 (0.85–4.11) 0.751 0.121 / / /
AF(%) 4(3.74) 51(15.55) 4.74 (1.67–13.44) 2.52 0.003 5.77 (1.28–26.11) 4.44 0.023
Diabetes mellitus(%) 22(20.56) 105(30.01) 1.06 (0.62–1.83) 0.29 0.812 / / /
Family history of cardiovascular and cerebrovascular events(%) 14(13.08) 52(15.85) 1.25 (0.66–2.36) 0.4 0.489 / / /
Smoking history (%) 26(24.30) 65(19.82) 1.16 (0.73–1.85) 0.27 0.693 / / /
TC, mmol/L 4.85 ± 1.09 3.97 ± 1.05 0.45 (0.36–0.58) 0.05 <0.05 0.04 (0.01–0.16) 0.02 <0.05
TG, mmol/L 1.65 ± 0.72 1.55 ± 1.07 0.91 (0.74–1.12) 0.09 0.373 / / /
HDL, mmol/L 1.46 ± 0.41 1.13 ± 0.53 0.30 (0.39–0.50) 0.08 <0.05 / / /
LDL, mmol/L 2.64 ± 0.92 2.44 ± 0.88 0.78 (0.62–1.00) 0.09 0.049 6.55 (1.09–39.58) 6.01 0.04
FSG, mmol/L 5.57 ± 1.22 6.70 ± 3.20 1.24 (1.10–1.42) 0.08 0.001 / / /
HbA1c 5.67 ± 1.11 6.75 ± 1.69 2.04 (1.56–2.67) 0.28 <0.05 2.28 (1.40–3.71) 0.56 0.001
XO, ng/mL 0.78 ± 0.51 1.76 ± 0.87 6.29 (4.13–9.56) 1.34 <0.05 8.68 (4.62–14.33) 2.8 <0.05

BMI, Body mass index; CHD, Coronary heart disease; AF, Atrial fibrillation; TC, Total cholesterol; TG, Triglyceride; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; FSG, Fasting blood glucose; HbA1c, Glycosylated hemoglobin; XO, Xanthine oxidase.